Condition
Fear of Spiders
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 4 (1)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06982183Phase 4RecruitingPrimary
The Effects of Propranolol, Hydrocortisone, and Morphine on Military-Relevant Performance Outcomes
NCT05193383Not ApplicableCompletedPrimary
Neural Mechanisms of Imaginal and in Vivo Exposure
NCT05168592Not ApplicableCompletedPrimary
The Neural Mechanisms of Imaginal Extinction
NCT03907345Not ApplicableCompletedPrimary
Generalized Fear Extinction to Untreated Fear Stimuli in Specific Phobias After Exposure
NCT04162509Not ApplicableCompletedPrimary
Efficacy of a Gamified Augmented Reality Exposure-based Application in Subjects With Fear of Spiders
Showing all 5 trials